Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Irinotecan hydrochloride trihydrate

Irinotecan hydrochloride trihydrate

pharmaceutical raw materials
Irinotecan hydrochloride trihydrate structure

Irinotecan hydrochloride trihydrate 

structure
  • CAS No:

    136572-09-3

  • Formula:

    C33H38N4O6.ClH.3H2O

  • Chemical Name:

    Irinotecan hydrochloride trihydrate

  • Synonyms:

    [1,4′-Bipiperidine]-1′-carboxylic acid,(4S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-9-yl ester,hydrochloride,hydrate (1:1:3);[1,4′-Bipiperidine]-1′-carboxylic acid,4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-9-yl ester,monohydrochloride,trihydrate,(S)-;[1,4′-Bipiperidine]-1′-carboxylic acid,(4S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-9-yl ester,monohydrochloride,trihydrate;1H-Pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline,[1,4′-bipiperidine]-1′-carboxylic acid deriv.;Irinotecan hydrochloride hydrate;Irinotecan hydrochloride trihydrate;Onivyde;Onivyde pegylated liposomal

  • Categories:

    Biochemical Engineering  >  Biosynthetic Natural Products

Description

White powderChEBI: A hydrate that is the trihydrate form of irinotecan hydrochloride. Onivyde is used in combination with fluorouracil and leucovorin, for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine based therapy. It is converted via hydrolysis of the carbamate linkage to its active metabolite, SN-38, which is ~1000 times more active.


Irinotecan hydrochloride hydrate is a hydrate that is the trihydrate form of irinotecan hydrochloride. Onivyde is used in combination with fluorouracil and leucovorin, for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine-based therapy. It is converted via hydrolysis of the carbamate linkage to its active metabolite, SN-38, which is ~1000 times more active. It has a role as an EC 5.99.1.2 (DNA topoisomerase) inhibitor, an antineoplastic agent, an apoptosis inducer and a prodrug. It contains an irinotecan hydrochloride (anhydrous).|Irinotecan Hydrochloride is the hydrochloride salt of a semisynthetic derivative of camptothecin, a cytotoxic, quinoline-based alkaloid extracted from the Asian tree Camptotheca acuminata. Irinotecan, a prodrug, is converted to a biologically active metabolite 7-ethyl-10-hydroxy-camptothecin (SN-38) by a carboxylesterase-converting enzyme. One thousand-fold more potent than its parent compound irinotecan, SN-38 inhibits topoisomerase I activity by stabilizing the cleavable complex between topoisomerase I and DNA, resulting in DNA breaks that inhibit DNA replication and trigger apoptotic cell death. Because ongoing DNA synthesis is necessary for irinotecan to exert its cytotoxic effects, it is classified as an S-phase-specific agent.|A semisynthetic camptothecin derivative that inhibits DNA TOPOISOMERASE I to prevent nucleic acid synthesis during S PHASE. It is used as an antineoplastic agent for the treatment of COLORECTAL NEOPLASMS and PANCREATIC NEOPLASMS.

Irinotecan hydrochloride trihydrate Basic Attributes

677.18

676.287537

1308068-626-2

042LAQ1IIS

C1381

L01CE02

29349990

Characteristics

116

4.57600

Pale yellow to yellow crystalline powder

256.5 °C

257°C(lit.)

482ºC

Safety Information

22

20/21-22

DW1060750

P201, P202, P264, P270, P281, P301+P312, P308+P313, P330, P405, P501

H302

|Danger|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P201, P202, P264, P270, P281, P301+P312, P308+P313, P330, P405, and P501|Aggregated GHS information provided by 15 companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Drug Information

Treatment of metastatic adenocarcinoma of the pancreas, in combination with 5 fluorouracil (5 FU) and leucovorin (LV), in adult patients who have progressed following gemcitabine based therapy.|Drug: Irinotecanhydrochloride|Drug: Irinotecan-hydrochloride-liposome

Compounds that inhibit the activity of DNA TOPOISOMERASE I. (See all compounds classified as Topoisomerase I Inhibitors.)

7 Ethyl 10 hydroxycamptothecin

Irinotecan hydrochloride trihydrate Use and Manufacturing

Methods of Manufacturing

Irinotecan HCl (4.8 g), water (30 ml), ethanol (10 ml) and 5 percent HCl (0.3 ml) were charged. The mixture was heated to 75-80 °C and stirred until all dissolved. The solution was cooled to 65 Irinotecan HCl (4.8 g), water (30 ml), ethanol (10 ml) and 5 percent HCl (0.3 ml) were charged. The mixture was heated to 75-80 °C and stirred until all dissolved. The solution was cooled to 65

Uses

A DNA topoisomerase inhibitor.

Human drugs -> Orphan -> Onivyde pegylated liposomal (previously known as Onivyde) -> EMA Drug Category|Antineoplastic agents -> Human pharmacotherapeutic group|Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients

Computed Properties

Molecular Weight:677.2
Hydrogen Bond Donor Count:5
Hydrogen Bond Acceptor Count:11
Rotatable Bond Count:5
Exact Mass:676.2875067
Monoisotopic Mass:676.2875067
Topological Polar Surface Area:116
Heavy Atom Count:47
Complexity:1200
Defined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:5
Compound Is Canonicalized:Yes

Recommended Suppliers of Irinotecan hydrochloride trihydrate

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.